# Levosimendan in Acute Decompensated Heart Failure

> **NCT07262723** · PHASE2,PHASE3 · NOT_YET_RECRUITING · sponsor: **Chittagong Medical College** · enrollment: 332 (estimated)

## Conditions studied

- Acute Decompensated Heart Failure (ADHF)

## Interventions

- **DRUG:** Levosimendan
- **OTHER:** Standard care

## Key facts

- **NCT ID:** NCT07262723
- **Lead sponsor:** Chittagong Medical College
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-12-01
- **Primary completion:** 2026-10-30
- **Final completion:** 2026-12-30
- **Target enrollment:** 332 (ESTIMATED)
- **Last updated:** 2025-12-04

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07262723

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07262723, "Levosimendan in Acute Decompensated Heart Failure". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07262723. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*